APA (7th ed.) Citation

(2010). Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women.

Chicago Style (17th ed.) Citation

Bcl-2 Antagonist Killer 1 (BAK1) Polymorphisms Influence the Risk of Developing Autoimmune Rheumatic Diseases in Women. 2010.

MLA (8th ed.) Citation

Bcl-2 Antagonist Killer 1 (BAK1) Polymorphisms Influence the Risk of Developing Autoimmune Rheumatic Diseases in Women. 2010.

Warning: These citations may not always be 100% accurate.